Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study

BACKGROUND: Mandatory trial registration, and later results reporting, were proposed to mitigate selective clinical trial publication and outcome reporting. The Food and Drug Administration (FDA) Amendments Act (FDAAA) was enacted by Congress on September 27, 2007, requiring the registration of all...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Constance X., Becker, Jessica E., Phillips, Adam T., Garritano, James M., Krumholz, Harlan M., Miller, Jennifer E., Ross, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199729/
https://www.ncbi.nlm.nih.gov/pubmed/30352601
http://dx.doi.org/10.1186/s13063-018-2957-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199729/
https://www.ncbi.nlm.nih.gov/pubmed/30352601
http://dx.doi.org/10.1186/s13063-018-2957-0

Ejemplares similares